Diamyd Medical develops therapies for type 1 diabetes|Anders EssenMoller,Chairman,Diamyd Medical 00:10:00
Born in 1941. M.Sc. Founder of and CEO during 1996-2007 of Diamyd Medical and Chairman 2007 –2015. Independent of the Company, major owner. Founder of Synectics Medical AB, sold to Medtronic, Inc. in 1996. Chairman of NextCell Pharma AB.